世界の脂質異常症治療薬市場：市場規模・現状・予測

• 英文タイトル：Global Dyslipidemia Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7136
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、脂質異常症治療薬のグローバル市場について調査・分析したレポートで、種類別（スタチン、非スタチン、組み合わせ薬）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・脂質異常症治療薬の世界市場規模
・主要企業別市場シェア
・脂質異常症治療薬の世界市場規模：種類別（スタチン、非スタチン、組み合わせ薬）
・脂質異常症治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・脂質異常症治療薬のアメリカ市場規模（種類別、用途別）
・脂質異常症治療薬のヨーロッパ市場規模（種類別、用途別）
・脂質異常症治療薬の中国市場規模（種類別、用途別）
・脂質異常症治療薬の日本市場規模（種類別、用途別）
・脂質異常症治療薬の東南アジア市場規模（種類別、用途別）
・脂質異常症治療薬のインド市場規模（種類別、用途別）
・脂質異常症治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・脂質異常症治療薬の世界市場予測（2019年-2025年）
・脂質異常症治療薬の地域別市場予測（2019年-2025年）
...

Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In this report, Dyslipidemia Therapeutics are divided into statins, non-statins and combinations drugs.In 2018, the global Dyslipidemia Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dyslipidemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dyslipidemia Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
Sanofi
Amgen
Merck
Novartis
Abbott Laboratories
AstraZeneca
Mylan
Kowa Pharmaceuticals
Novelion Therapeutics

Market segment by Type, the product can be split into
Statins
Non-Statins
Combinations Drugs

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dyslipidemia Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Dyslipidemia Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dyslipidemia Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dyslipidemia Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Statins
1.4.3 Non-Statins
1.4.4 Combinations Drugs
1.5 Market by Application
1.5.1 Global Dyslipidemia Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dyslipidemia Therapeutics Market Size
2.2 Dyslipidemia Therapeutics Growth Trends by Regions
2.2.1 Dyslipidemia Therapeutics Market Size by Regions (2014-2025)
2.2.2 Dyslipidemia Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dyslipidemia Therapeutics Market Size by Manufacturers
3.1.1 Global Dyslipidemia Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Dyslipidemia Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dyslipidemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Dyslipidemia Therapeutics Key Players Head office and Area Served
3.3 Key Players Dyslipidemia Therapeutics Product/Solution/Service
3.4 Date of Enter into Dyslipidemia Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dyslipidemia Therapeutics Market Size by Type (2014-2019)
4.2 Global Dyslipidemia Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Dyslipidemia Therapeutics Market Size (2014-2019)
5.2 Dyslipidemia Therapeutics Key Players in United States
5.3 United States Dyslipidemia Therapeutics Market Size by Type
5.4 United States Dyslipidemia Therapeutics Market Size by Application

6 Europe
6.1 Europe Dyslipidemia Therapeutics Market Size (2014-2019)
6.2 Dyslipidemia Therapeutics Key Players in Europe
6.3 Europe Dyslipidemia Therapeutics Market Size by Type
6.4 Europe Dyslipidemia Therapeutics Market Size by Application

7 China
7.1 China Dyslipidemia Therapeutics Market Size (2014-2019)
7.2 Dyslipidemia Therapeutics Key Players in China
7.3 China Dyslipidemia Therapeutics Market Size by Type
7.4 China Dyslipidemia Therapeutics Market Size by Application

8 Japan
8.1 Japan Dyslipidemia Therapeutics Market Size (2014-2019)
8.2 Dyslipidemia Therapeutics Key Players in Japan
8.3 Japan Dyslipidemia Therapeutics Market Size by Type
8.4 Japan Dyslipidemia Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dyslipidemia Therapeutics Market Size (2014-2019)
9.2 Dyslipidemia Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Dyslipidemia Therapeutics Market Size by Type
9.4 Southeast Asia Dyslipidemia Therapeutics Market Size by Application

10 India
10.1 India Dyslipidemia Therapeutics Market Size (2014-2019)
10.2 Dyslipidemia Therapeutics Key Players in India
10.3 India Dyslipidemia Therapeutics Market Size by Type
10.4 India Dyslipidemia Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Dyslipidemia Therapeutics Market Size (2014-2019)
11.2 Dyslipidemia Therapeutics Key Players in Central & South America
11.3 Central & South America Dyslipidemia Therapeutics Market Size by Type
11.4 Central & South America Dyslipidemia Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dyslipidemia Therapeutics Introduction
12.1.4 Pfizer Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dyslipidemia Therapeutics Introduction
12.2.4 Sanofi Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dyslipidemia Therapeutics Introduction
12.3.4 Amgen Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.3.5 Amgen Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dyslipidemia Therapeutics Introduction
12.4.4 Merck Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dyslipidemia Therapeutics Introduction
12.5.4 Novartis Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Abbott Laboratories
12.6.1 Abbott Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dyslipidemia Therapeutics Introduction
12.6.4 Abbott Laboratories Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.6.5 Abbott Laboratories Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dyslipidemia Therapeutics Introduction
12.7.4 AstraZeneca Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dyslipidemia Therapeutics Introduction
12.8.4 Mylan Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 Kowa Pharmaceuticals
12.9.1 Kowa Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dyslipidemia Therapeutics Introduction
12.9.4 Kowa Pharmaceuticals Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.9.5 Kowa Pharmaceuticals Recent Development
12.10 Novelion Therapeutics
12.10.1 Novelion Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dyslipidemia Therapeutics Introduction
12.10.4 Novelion Therapeutics Revenue in Dyslipidemia Therapeutics Business (2014-2019)
12.10.5 Novelion Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Dyslipidemia Therapeutics Key Market Segments
Table Key Players Dyslipidemia Therapeutics Covered
Table Global Dyslipidemia Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dyslipidemia Therapeutics Market Size Market Share by Type 2014-2025
Figure Statins Figures
Table Key Players of Statins
Figure Non-Statins Figures
Table Key Players of Non-Statins
Figure Combinations Drugs Figures
Table Key Players of Combinations Drugs
Table Global Dyslipidemia Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Dyslipidemia Therapeutics Report Years Considered
Table Global Dyslipidemia Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Dyslipidemia Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dyslipidemia Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Dyslipidemia Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Dyslipidemia Therapeutics Market Share by Regions 2014-2019
Figure Global Dyslipidemia Therapeutics Market Share by Regions 2014-2019
Figure Global Dyslipidemia Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Dyslipidemia Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dyslipidemia Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Dyslipidemia Therapeutics Market Share by Manufacturers in 2018
Table Global Dyslipidemia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dyslipidemia Therapeutics Product/Solution/Service
Table Date of Enter into Dyslipidemia Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Dyslipidemia Therapeutics Market Size Share by Type (2014-2019)
Figure Global Dyslipidemia Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Dyslipidemia Therapeutics Market Size Share by Application (2014-2019)
Figure Global Dyslipidemia Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Dyslipidemia Therapeutics Revenue Market Share by Application in 2018
Figure United States Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table United States Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table United States Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure Europe Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table Europe Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table Europe Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure China Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table China Dyslipidemia Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table China Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure Japan Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table Japan Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table Japan Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table Southeast Asia Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure India Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table India Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table India Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Dyslipidemia Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dyslipidemia Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dyslipidemia Therapeutics Market Share (2018-2019)
Table Central & South America Dyslipidemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dyslipidemia Therapeutics Market Share by Type (2014-2019)
Table Central & South America Dyslipidemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dyslipidemia Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Dyslipidemia Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Amgen Company Details
Table Amgen Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table Merck Company Details
Table Merck Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Mylan Company Details
Table Mylan Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Mylan Recent Development
Table Kowa Pharmaceuticals Company Details
Table Kowa Pharmaceuticals Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Kowa Pharmaceuticals Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Kowa Pharmaceuticals Recent Development
Table Novelion Therapeutics Company Details
Table Novelion Therapeutics Revenue in Dyslipidemia Therapeutics Business (2014-2019)(Million US$)
Figure Novelion Therapeutics Revenue Growth Rate in Dyslipidemia Therapeutics Business (2014-2019)
Table Novelion Therapeutics Recent Development
Table Global Dyslipidemia Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Dyslipidemia Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Dyslipidemia Therapeutics Market Size Share by Regions in 2025
Figure United States Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dyslipidemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Dyslipidemia Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Dyslipidemia Therapeutics Market Size by Product (2019-2025)
Figure Global Dyslipidemia Therapeutics Market Size by Product in 2025
Table Global Dyslipidemia Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Dyslipidemia Therapeutics Market Size by Application (2019-2025)
Figure Global Dyslipidemia Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界のデジタル治療薬＆ウェルネス市場：市場規模・現状・予測

Global Digital Therapeutics & Wellness Market Size, Status and Forecast 2019-2025
QYR9N7107 2019年6月14日 107Pages
当資料は、デジタル治療薬＆ウェルネスのグローバル市場について調査・分析したレポートで、種類別（ソフトウェア、デバイス）、用途別（心血管疾患と高血圧、糖尿病と前糖尿病、肥満と減量、禁煙、その他のデジタル治療学）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...

世界の骨粗鬆症治療薬市場：市場規模・現状・予測

Global Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7734 2019年6月14日 94Pages
当資料は、骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗吸収薬、同化薬）、用途別（男性、女性）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・骨粗鬆症治療薬の...

世界の過活動膀胱治療学市場：市場規模・現状・予測

Global Overactive Bladder Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7750 2019年6月14日 92Pages
当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別（抗コリン作用薬、ミラベグロン、ボトックス）、用途別（特発性過活動膀胱、神経性過活動膀胱）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界の変形性関節症治療市場：市場規模・現状・予測

Global Osteoarthritis Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7733 2019年6月14日 103Pages
当資料は、変形性関節症治療のグローバル市場について調査・分析したレポートで、種類別（経口、注入、外部）、用途別（医療、パーソナルケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・変形...

世界の胃炎治療薬市場：市場規模・現状・予測

Global Gastritis Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7226 2019年6月14日 96Pages
当資料は、胃炎治療薬のグローバル市場について調査・分析したレポートで、種類別（酸遮断薬、抗生物質、制酸剤、ヒスタミンブロッカー、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...

世界の女性の健康治療市場：市場規模・現状・予測

Global Women Health Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8208 2019年6月14日 94Pages
当資料は、女性の健康治療のグローバル市場について調査・分析したレポートで、種類別（更年期障害、子宮内膜症、閉経後骨粗鬆症、乳がん、多嚢胞性卵巣症候群、その他）、用途別（画像診断センター、病院と診療所、ホームケア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...

世界の膵がん治療市場：市場規模・現状・予測

Global Pancreatic Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7757 2019年6月14日 99Pages
当資料は、膵がん治療のグローバル市場について調査・分析したレポートで、種類別（生物学、化学療法、ターゲット療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
<...

世界の閉経後骨粗鬆症治療薬市場：市場規模・現状・予測

Global Postmenopausal Osteoporosis Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7867 2019年6月14日 97Pages
当資料は、閉経後骨粗鬆症治療薬のグローバル市場について調査・分析したレポートで、種類別（ビスホスホネート、ホルモン、ストロンチウムラネレート、ラロキシフェン、デノスマブ、その他）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）...

世界の酒さ治療薬市場：市場規模・現状・予測

Global Rosacea Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7983 2019年6月14日 93Pages
当資料は、酒さ治療薬のグローバル市場について調査・分析したレポートで、種類別（抗菌剤、アルファアゴニスト、レチノイド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界のシェーグレン症候群の治療薬市場：市場規模・現状・予測

Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N8047 2019年6月14日 99Pages
当資料は、シェーグレン症候群の治療薬のグローバル市場について調査・分析したレポートで、種類別（一次、二次）、用途別（臨床、病院）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・シェーグレ...

世界の閉経後骨粗鬆症治療薬市場：市場規模・現状・予測 Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone.The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. In 2018, the globa…
世界の睡眠障害治療薬市場：市場規模・現状・予測 Sleep disorders result in a lack of deep and restorative sleep.The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. In 2018, the global Sleep Disorder Therapeutics market size was xx…
世界の白斑治療学市場：市場規模・現状・予測 Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. The patches of skin affected become white and usually have sharp margins. The hair from the skin may also become white.In 2018, the global Vitiligo Therapeutics market size was xx million US$ and it is …
世界の産後うつ病治療薬市場：市場規模・現状・予測 Postpartum depression is a prevalent disorder affecting many women of reproductive age.Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depres…
世界の酒さ治療薬市場：市場規模・現状・予測 In 2018, the global Rosacea Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rosacea Therapeutics status, future forecast, growth opportunity, key market and key players. …